Neural patterns predicted which participants classified as high or low performers based on attention networks during the game. LOS ANGELES--(BUSINESS WIRE)--Kernel, a leader in non-invasive ...

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, today announced that ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced the sponsorship of ...

LOS ANGELES--(BUSINESS WIRE)-- Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular ...

Cybin Inc. CYBN announced key highlights from its successful feasibility study conducted by its partner HI, LLC dba Kernel that tested its wearable technology to measure ketamine's psychedelic effect ...

Please provide your email address to receive an email when new articles are posted on . Neurotechnology firm Kernel and biopharmaceutical company Cybin announced promising pilot results from a ...

New feasibility study indicates that VR has the potential to drive physiological changes in the body and brain associated with pain relief LOS ANGELES, Feb. 8, 2024 /PRNewswire/ -- AppliedVR ®, a ...

At last year's SPIE Photonics West, California-based neurotech start-up Kernel revealed the system architecture of its proposed Kernel Flux optically-pumped magnetometer platform designed to record ...

Peering into the human brain has never been easy. For decades, neuroscientists have relied on heavy, expensive machines to measure blood flow and oxygen levels that reveal how the brain works. These ...